Artikel Ilmiah : G1F012078 a.n. NOVITA CAHYA PUSPITASARI
| NIM | G1F012078 |
|---|---|
| Namamhs | NOVITA CAHYA PUSPITASARI |
| Judul Artikel | ANALISIS BIAYA MINIMAL KONVERSI PENGGUNAAN ANTIBIOTIK CIPROFLOXACIN INTRAVENA KE ORAL DI RSUD AJIBARANG |
| Abstrak (Bhs. Indonesia) | Penggunaan antibiotik di rumah sakit dapat mencapai 30-80% dari anggaran rumah sakit. Salah satu cara menghemat biaya yaitu denga cara konversi terapi. Penelitian ini bertujuan mengetahui potensi penghematan dari terapi konversi antibiotik ciprofloxacin intravena ke oral. Penelitian ini bersifat deskriptif. Data diperoleh secara retrospektif dari bagian keuangan dan catatan rekam medik pasien di RSUD Ajibarang yang mendapatkan ciprofloxacin intravena pada April 2015-Maret 2016. Penelitian ini menggunakan perspektif rumah sakit dan menggunakan metode analisis biaya minimal. Sampel yang digunakan sebanyak 103 pasien rawat inap yang mendapatkan ciprofloxacin intravena. Konversi terapi diasumsikan dapat dilakukan apabila pasien memenuhi syarat konversi. Analisis dilakukan dengan membandingkan selisih biaya pengobatan dan total dengan biaya konversi. Sebanyak 64,07% (66 pasien) dapat dilakukan konversi terapi. Presentase penghematan biaya pengobatan ciprofloxacin intravena ke oral sebesar 83,48%±22,01% dan penghematan terhadap biaya total 3,67%±1,99%. Kelompok penyakit yang memiliki penghematan pengobatan terbesar adalah thypoid yang mencapai penghematan terhadap biaya pengobatan 97,93% dan penghematan terhadap biaya total terbesar pada penyakit abses sbesar 5,66%. Hasil penelitian menunjukkan konversi terapi ciprofloxacin intravena ke oral dapat menghemat biaya pengobatan maupun biaya total di rumah sakit. Kata kunci: Ciprofloxacin, Konversi Terapi, Analisis Biaya Minimal |
| Abtrak (Bhs. Inggris) | Antibiotics of the usage in hospitals can reach up to 30-80% of hospitals budget. One way to save the cost is to switch therapy. This study aimed to know of the saving potential from switching therapy from intravenous antibiotic ciprofloxacin to oral. This was a descriptive study. The retrospective data were collected from financial and medical records of patients in RSUD Ajibarang that received intravenous ciprofloxacin from April 2015-March 2016. This study was perceived through the hospital’s perspective and uses cost minimization analysis method. 103 inpatients receiving intravenous ciprofloxacin were used as samples. Switching therapy may be done if patients fulfil the switching requirements. Analysis was done by comparing the difference in cost of treatment and total cost to switch cost. As much as 64,07% (66 patients) were able to do switching therapy. The percentage of cost saving from intravenous ciprofloxacin to oral treatment was 83,48%±22,01% and the cost saving toward the total cost was 3,67%±1,99%. The disease group which has the biggest cost saving in treatment cost was typhoid which reaches 97,93% and abscess which reaches 5,66% toward total cost. Results showed that switching of intravenous ciprofloxacin to oral can save the cost of treatment and total cost in hospitals. Keywords: Ciprofloxacin, Switch Therapy, Cost Minimization Analysis |
| Kata kunci | Kata kunci: Ciprofloxacin, Konversi Terapi, Analisis Biaya Minimal |
| Pembimbing 1 | Nia Kurnia Sholihat, M.Sc., Apt |
| Pembimbing 2 | Vitis Vini Fera R.U., M.Sc., Apt |
| Pembimbing 3 | |
| Tahun | 2016 |
| Jumlah Halaman | 10 |
| Tgl. Entri | 2016-11-25 21:19:35.325109 |